Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing
- 1 August 1988
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 10 (4) , 221-240
- https://doi.org/10.1016/0732-8893(88)90094-6
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Enterohepatic circulation of NY-198, a new difluorinated quinolone, in ratsAntimicrobial Agents and Chemotherapy, 1988
- Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicidDiagnostic Microbiology and Infectious Disease, 1987
- RO 23-6240 (AM-833), a new fluoroquinolone: In vitro antimicrobial activity and tentative disk diffusion interpretive criteriaDiagnostic Microbiology and Infectious Disease, 1987
- Bactericidal activities of ten different fluoroquinolones against selected enterobacteriaceaeDiagnostic Microbiology and Infectious Disease, 1987
- Resistance to ten different fluoroquinolone antibiotics following in vitro exposures to nalidixic acidDiagnostic Microbiology and Infectious Disease, 1987
- In vitro activity of Ro 23-6240, a new fluorinated 4-quinoloneAntimicrobial Agents and Chemotherapy, 1986
- The fluoroquinolones: pharmacology, clinical uses, and toxicities in humansAntimicrobial Agents and Chemotherapy, 1985
- The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroAntimicrobial Agents and Chemotherapy, 1985
- In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620Antimicrobial Agents and Chemotherapy, 1985
- Evaluation of in vitro antibacterial activity of enoxacin: Comparison with other orally absorbed antimicrobial agents, proposed disk diffusion test interpretive criteria, and quality control limitsDiagnostic Microbiology and Infectious Disease, 1985